BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 11302546)

  • 1. Historical and current perspectives on bone marrow transplantation for prevention and treatment of immunodeficiencies and autoimmunities.
    Good RA; Verjee T
    Biol Blood Marrow Transplant; 2001; 7(3):123-35. PubMed ID: 11302546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress toward production of immunologic tolerance with no or minimal toxic immunosuppression for prevention of immunodeficiency and autoimmune diseases.
    Good RA
    World J Surg; 2000 Jul; 24(7):797-810. PubMed ID: 10833246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical investigations that subserve efforts to employ bone marrow transplantation for rheumatoid or autoimmune diseases.
    Good RA; Ikehara S
    J Rheumatol Suppl; 1997 May; 48():5-12. PubMed ID: 9150111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow transplantation for autoimmune diseases.
    Ikehara S
    Acta Haematol; 1998; 99(3):116-32. PubMed ID: 9587393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term observation after simultaneous lung and intra-bone marrow-bone marrow transplantation.
    Kaneda H; Adachi Y; Saito Y; Ikebukuro K; Machida H; Suzuki Y; Minamino K; Zhang Y; Iwasaki M; Nakano K; Koike Y; Wang J; Imamura H; Ikehara S
    J Heart Lung Transplant; 2005 Sep; 24(9):1415-23. PubMed ID: 16143265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed bone marrow or mixed stem cell transplantation for prevention or treatment of lupus-like diseases in mice.
    Good RA; Wang BY; El-Badri NS; Steele A; Verjee T
    Exp Nephrol; 2002; 10(5-6):408-20. PubMed ID: 12381926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term donor-specific tolerance in rat cardiac allografts by intrabone marrow injection of donor bone marrow cells.
    Guo K; Inaba M; Li M; An J; Cui W; Song C; Wang J; Cui Y; Sakaguchi Y; Tsuda M; Omae M; Ando Y; Li Q; Wang X; Feng W; Ikehara S
    Transplantation; 2008 Jan; 85(1):93-101. PubMed ID: 18192918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of diabetes in nonobese diabetic mice by nonmyeloablative allogeneic bone marrow transplantation.
    Elkin G; Prigozhina TB; Slavin S
    Exp Hematol; 2004 Jun; 32(6):579-84. PubMed ID: 15183899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced-intensity conditioning for the treatment of malignant and life-threatening non-malignant disorders.
    Slavin S; Aker M; Shapira MY; Resnick I; Bitan M; Or R
    Clin Transpl; 2003; ():275-82. PubMed ID: 15387119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow transplantation in congenital immunodeficiency diseases.
    Porta F; Friedrich W
    Bone Marrow Transplant; 1998 Apr; 21 Suppl 2():S21-3. PubMed ID: 9630319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New strategies for BMT, organ transplantation, and regeneration therapy.
    Ikehara S
    Hematology; 2003 Apr; 8(2):77-81. PubMed ID: 12745656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel method of bone marrow transplantation (BMT) for intractable autoimmune diseases.
    Ikehara S
    J Autoimmun; 2008 May; 30(3):108-15. PubMed ID: 18249091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New strategies for allogeneic BMT.
    Ikehara S
    Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S73-5. PubMed ID: 12931248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic bone marrow transplantation in models of experimental autoimmune encephalomyelitis: evidence for a graft-versus-autoimmunity effect.
    Van Wijmeersch B; Sprangers B; Rutgeerts O; Lenaerts C; Landuyt W; Waer M; Billiau AD; Dubois B
    Biol Blood Marrow Transplant; 2007 Jun; 13(6):627-37. PubMed ID: 17531772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current progress in chimerism and donor-specific tolerance.
    Jankowski RA; Ildstad ST
    Transplant Proc; 1996 Aug; 28(4):2071-4. PubMed ID: 8769159
    [No Abstract]   [Full Text] [Related]  

  • 17. Bone marrow transplantation as a strategy for the treatment of autoimmune hearing loss in MRL/Mp-lpr/lpr mice.
    Iwai H; Lee S; Inaba M; Baba S; Yamashita T; Ikehara S
    J Neuroimmunol; 2005 Nov; 168(1-2):76-82. PubMed ID: 16146652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal models of endocrine/organ-specific autoimmune diseases: do they really help us to understand human autoimmunity?
    Lam-Tse WK; Lernmark A; Drexhage HA
    Springer Semin Immunopathol; 2002 Dec; 24(3):297-321. PubMed ID: 12503056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new bone marrow transplantation method for stem cell disorders.
    Ikehara S
    Ann N Y Acad Sci; 2009 Sep; 1173():774-80. PubMed ID: 19758228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic chimerism induces renal and skin allograft tolerance in DLA-identical dogs.
    Tillson M; Niemeyer GP; Welch JA; Brawner W; Swaim SF; Rynders P; Lenz SD; Dean B; Lothrop CD
    Exp Hematol; 2006 Dec; 34(12):1759-70. PubMed ID: 17157174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.